Special Issue "Occupational Exposure to Antineoplastic Drugs"
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Occupational Safety and Health".
Deadline for manuscript submissions: 31 May 2022.
Interests: occupational medicine; public health; nanosafety; active aging; occupational toxicology; industrial health; biological monitoring; occupational risk assessment; occupational diseases; occupational carcinogens
Special Issues, Collections and Topics in MDPI journals
Interests: hazardous drugs; occupational drug exposures; chemical exposures; risk assessment; occupational toxicology; chemical exposures; hazard identification
Interests: monitoring exposure of workers to antibiotics and hazardous drugs in hospitals and in the pharmaceutical industry
Interests: chromatography; mass spectrometry; analytical chemistry (UHPLC-MS/MS); occupational exposure to antineoplastic drugs (ADs); drug delivery systems (DDSs); micro-nanoparticles
Antineoplastic agents are medications used to treat cancer that can cause adverse health effects in patients treated with these drugs. In particular, they can be harmful to both cancerous and healthy cells. This is obviously acceptable for cancer patients who have a life-threatening disease. However, healthcare professionals and veterinary workers occupationally exposed to antineoplastic drugs should be protected, and consequently their exposure to these agents eliminated or reduced as much as possible.
In this Special Issue, we hope to bring together significant research that advances the knowledge base on occupational exposure to antineoplastic drugs. Of particular interest will be papers that evaluate occupational exposure to antineoplastic drugs through biological and environmental monitoring. In vitro, in vivo, and human studies, as well as mechanistic studies that contribute to the understanding of worker health effects are welcome. Additionally, papers that describe risk assessments, bases for occupational exposure limit (OEL) development, and evidence-based risk management are also being sought. This Special Issue will focus on the publication of original manuscripts and critical reviews to advance the understanding of the possible health effects of antineoplastic drugs and the means to protect workers exposed to them.
Prof. Dr. Ivo Iavicoli
Dr. Jerald L. Ovesen
Dr. Paul J. M. Sessink
Dr. Cristina Sottani
Dr. Elena Grignani
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- environmental monitoring
- biological monitoring